Serif Senturk

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

Cancer gene therapy

Communications biology

Cells

International journal of molecular sciences

Izmir Biomedicine and Genome Center

Bilkent University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Izmir Biomedicine and Genome Center May 11 2017

Turkey

Research Group Leader

Dokuz Eylul University, International Biomedicine and Genome Institute Nov 02 2015

Turkey

Associate Professor :: Genome Sciences and Molecular Biotechnology

Cold Spring Harbor Laboratory Nov 10 2010 - Oct 31 2015

United States

Postdoctoral Fellow :: Cancer Center

Education History

Bilkent University Sep 25 2003 - Jul 10 2010

Turkey

PHD :: Molecular Biology and Genetics

Bogazici University Sep 20 1998 - Jul 04 2003

Turkey

BSC :: Molecular Biology and Genetics

Publications

Gizem Ozgun, Tutku Yaras, Burcu Akman, Gülden Özden-Yılmaz, Nick Landman, Gökhan Karakülah, Maarten van Lohuizen, Serif Senturk, Serap Erkek-Özhan
Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells. Cancer gene therapy 31 (4) (2024)
Gizem Ozgun, Tutku Yaras, Burcu Akman, Gülden Özden-Yılmaz, Nick Landman, Gökhan Karakülah, Maarten van Lohuizen, Serif Senturk, Serap Erkek-Özhan
Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells. Cancer gene therapy (2024)
Gizem Ozgun, Tutku Yaras, Burcu Akman, Gülden Özden-Yılmaz, Nick Landman, Gökhan Karakülah, Maarten van Lohuizen, Serif Senturk, Serap Erkek-Özhan
Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells. Cancer gene therapy 31 (4) (2024)
Gizem Ozgun, Tutku Yaras, Burcu Akman, Gülden Özden-Yılmaz, Nick Landman, Gökhan Karakülah, Maarten van Lohuizen, Serif Senturk, Serap Erkek-Özhan
Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells. Cancer gene therapy 31 (4) (2024)
Perihan Yagmur Guneri-Sozeri, Gülden Özden-Yılmaz, Asli Kisim, Ece Cakiroglu, Aleyna Eray, Hamdiye Uzuner, Gökhan Karakülah, Devrim Pesen-Okvur, Serif Senturk, Serap Erkek-Özhan
FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer. Communications biology 6 (1) (2023)
Perihan Yagmur Guneri-Sozeri, Gülden Özden-Yılmaz, Asli Kisim, Ece Cakiroglu, Aleyna Eray, Hamdiye Uzuner, Gökhan Karakülah, Devrim Pesen-Okvur, Serif Senturk, Serap Erkek-Özhan
FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer. Communications biology 6 (1) (2023)
Perihan Yagmur Guneri-Sozeri, Gülden Özden-Yılmaz, Asli Kisim, Ece Cakiroglu, Aleyna Eray, Hamdiye Uzuner, Gökhan Karakülah, Devrim Pesen-Okvur, Serif Senturk, Serap Erkek-Özhan
FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer. Communications biology 6 (1) (2023)
Gülden Özden-Yılmaz, Busra Savas, Ahmet Bursalı, Aleyna Eray, Alirıza Arıbaş, Serif Senturk, Ezgi Karaca, Gökhan Karakülah, Serap Erkek-Ozhan
Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines. Cells 12 (6) (2023)
Gülden Özden-Yılmaz, Busra Savas, Ahmet Bursalı, Aleyna Eray, Alirıza Arıbaş, Serif Senturk, Ezgi Karaca, Gökhan Karakülah, Serap Erkek-Ozhan
Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines. Cells 12 (6) (2023)
Perihan Yagmur Guneri-Sozeri, Gülden Özden-Yılmaz, Asli Kisim, Ece Cakiroglu, Aleyna Eray, Hamdiye Uzuner, Gökhan Karakülah, Devrim Pesen-Okvur, Serif Senturk, Serap Erkek-Özhan
FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer. Communications biology 6 (1) (2023)
Gülden Özden-Yılmaz, Busra Savas, Ahmet Bursalı, Aleyna Eray, Alirıza Arıbaş, Serif Senturk, Ezgi Karaca, Gökhan Karakülah, Serap Erkek-Ozhan
Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines. Cells 12 (6) (2023)
Medine Zeynep Gungor, Merve Uysal, Serif Senturk
The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications. Cancers 14 (4) (2022)
Medine Zeynep Gungor, Merve Uysal, Mehmet Ozturk, Serif Senturk
Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines. Journal of gastrointestinal cancer (2021)
Dilara Demirci, Bengisu Dayanc, Fatma Aybuke Mazi, Serif Senturk
The Jekyll and Hyde of Cellular Senescence in Cancer. Cells 10 (2) (2021)
Hasan Akbaba, Gulsah Erel-Akbaba, Serif Senturk
Special Focus Issue Part II: Recruitment of solid lipid nanoparticles for the delivery of CRISPR/Cas9: primary evaluation of anticancer gene editing. Nanomedicine (London, England) 16 (12) (2021)
Tugce Batur, Ayse Argundogan, Umur Keles, Zeynep Mutlu, Hani Alotaibi, Serif Senturk, Mehmet Ozturk
AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization. International journal of molecular sciences 22 (24) (2021)
Ece Cakiroglu, Serif Senturk
Genomics and Functional Genomics of Malignant Pleural Mesothelioma. International journal of molecular sciences 21 (17) (2020)

Serif Senturk.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Serif Senturk